These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 208736)

  • 1. The protective antigens of equine herpesvirus type 1.
    Papp-Vid G; Derbyshire JB
    Can J Comp Med; 1978 Apr; 42(2):219-26. PubMed ID: 208736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serologic and molecular comparisons of several equine herpesvirus type 1 strains.
    Turtinen LW; Allen GP; Darlington RW; Bryans JT
    Am J Vet Res; 1981 Dec; 42(12):2099-104. PubMed ID: 6280520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The proteins of equid herpesvirus 1 (EHV 1) recognised by equine antisera and their ability to promote antibody-dependent cell-mediated cytotoxicity.
    Bridges CG; Edington N
    Tierarztl Prax Suppl; 1987; 2():47-9. PubMed ID: 3035747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic relationships between equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus).
    Fitzpatrick DR; Studdert MJ
    Am J Vet Res; 1984 Oct; 45(10):1947-52. PubMed ID: 6208822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The characterization of equine herpes virus-1-infected cell polypeptides recognized by equine lymphocytes.
    Bridges CG; Ledger N; Edington N
    Immunology; 1988 Feb; 63(2):193-8. PubMed ID: 2832309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against lethal equine herpes virus type 1 (subtype 1) infection in hamsters by immune stimulating complexes (ISCOMs) containing the major viral glycoproteins.
    Cook RF; O'Neill T; Strachan E; Sundquist B; Mumford JA
    Vaccine; 1990 Oct; 8(5):491-6. PubMed ID: 2174599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of an inactivated vaccine for equine herpesvirus type 1 in a novel hamster model.
    Skinner GR; Davies J
    Intervirology; 2000; 43(1):27-35. PubMed ID: 10773735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the envelope surface glycoproteins of equine herpesvirus type 1.
    Turtinen LW; Allen GP
    J Gen Virol; 1982 Dec; 63(2):481-5. PubMed ID: 6296290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).
    Goodman LB; Wagner B; Flaminio MJ; Sussman KH; Metzger SM; Holland R; Osterrieder N
    Vaccine; 2006 Apr; 24(17):3636-45. PubMed ID: 16513225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies with neutralizing activity to equine herpesvirus 1.
    Shimizu M; Satou K; Nishioka N
    Arch Virol; 1989; 104(1-2):169-74. PubMed ID: 2538111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals.
    Guo PX; Goebel S; Davis S; Perkus ME; Languet B; Desmettre P; Allen G; Paoletti E
    J Virol; 1989 Oct; 63(10):4189-98. PubMed ID: 2550665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of equine herpesvirus type 1.
    Lawrence WC
    J Gen Virol; 1976 Apr; 31(1):81-91. PubMed ID: 177732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The virus neutralizing activity of antibodies specific to the envelope and nucleocapsid of equine herpesvirus type 1.
    Papp-Vid G; Derbyshire JB
    Can J Comp Med; 1979 Apr; 43(2):231-3. PubMed ID: 497891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A protective effect of epidermal powder immunization in a mouse model of equine herpesvirus-1 infection.
    Kondo T; McGregor M; Chu Q; Chen D; Horimoto T; Kawaoka Y
    Virology; 2004 Jan; 318(1):414-9. PubMed ID: 14972566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpesvirus sylvilagus I. Polypeptides of virions and nucleocapsids.
    Cohrs R; Rouhandeh H
    J Virol; 1982 Mar; 41(3):1063-72. PubMed ID: 7097852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of a chemically inactivated, adjuvanted vaccine to control abortigenic infection of mares by equine herpesvirus I.
    Bryans JT; Allen GP
    Dev Biol Stand; 1982; 52():493-8. PubMed ID: 6299858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of equine herpesvirus-1 antigen and the specific antibody by enzyme-linked immunosorbent assay.
    Dutta SK; Talbot NC; Myrup AC
    Am J Vet Res; 1983 Oct; 44(10):1930-4. PubMed ID: 6314855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serologic responses of pregnant thoroughbred mares to vaccination with an inactivated equine herpesvirus 1 vaccine.
    Bryans JT
    Am J Vet Res; 1980 Nov; 41(11):1743-6. PubMed ID: 6259970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity to equine herpesvirus type 1 (rhinopneumonitis): in vitro lymphocyte response.
    Wilks CR; Coggins L
    Am J Vet Res; 1976 May; 37(5):486-92. PubMed ID: 179451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: Efficacy of modified live-virus equine rhinopneumonitis vaccine.
    Stear RL; Bass EP; Beckenhauer WH
    Am J Vet Res; 1976 Mar; 37(3):349-51. PubMed ID: 176909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.